Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Neurologic Complications of Chimeric Antigen Receptor Therapy
Epidemiology and Pathogenesis Beginning in 2017, there has been a steady increase in use of U.S. Food and Drug Administration (FDA)-approved chimeric antigen receptor (CAR) T-cell products for refractory relapsed hematologic tumors. Various host factors like disease burden, pretreatment inflammation,…